Tranexamic Acid in Total Knee Arthroplasty

Phase 2

• Conditions: primary osteoerthritis.; Primary generalized (osteo)arthrosis; M15.0

• Registration Number: IRCT20190427043390N1
• Lead Sponsor: Vice chancellor for research, Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

All patients with knee articular cartilage destruction that do not respond to supportive treatments

Exclusion Criteria

revision

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Average amount of blood lost. Timepoint: During and after surgery. Method of measurement: Graduated cylinders in milliliters.

Secondary Outcome Measures

Name	Time	Method
Deep vein thrombosis , thromboembolism. Timepoint: during 3 month post-surgical. Method of measurement: physical examination.